TBPH
19.06 USD
+3.32%
Today
-0.47%
1D
Last seen at Tue, 24 Feb 2026 23:40:00 GMT+3
Market is closed
Sun
Closed
Mon
4:30 PM ~ 10:59 PM
Tue
4:30 PM ~ 10:59 PM
Wed
4:30 PM ~ 10:59 PM
Thu
4:30 PM ~ 10:59 PM
Fri
4:30 PM ~ 10:59 PM
Sat
Closed
Performance
1 Day
- 0.47 %
1 Week
+ 2.45 %
1 Month
- 4.24 %
3 Month
+ 3.95 %
6 Month
+ 39.53 %
1 Year
+ 116.95 %
Information
Name
Theravance Biopharma Inc Leveraged
Currency
USD
Standard Leverage
1X
Enhanced Leverage
3X
Overnight Fees Buy
-0.0191%
Overnight Fees Sell
0.0024%
Market Cap
700.02M
Avg Daily Volume
323.35K
52 Week High
15.15 USD
52 Week Low
7.9 USD
Trading Hours
See hours
Overnight Fees Calculator
| Daily Overnight Fee % | Daily Overnight Fee $ | |
|---|---|---|
| BUYS | -0.01910% | $(0.191) |
| SELLS | 0.00240% | $0.024 |
*Results displayed are estimates. Actual fees may differ from those shown as market conditions change.
Business Summary
Theravance Biopharma, Inc., a biopharmaceutical company, develops and commercializes of medicines in the United States. It offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist for the treatment of chronic obstructive pulmonary disease (COPD). The company's product includes Ampreloxetine, an investigational norepinephrine reuptake inhibitor that has completed Phase III study for neurogenic orthostatic hypotension; and TRELEGY for the treatment of COPD and asthma. It has a strategic collaboration agreement with Viatris Inc. for the development and commercialization of revefenacin, including YUPELRI. Theravance Biopharma, Inc. was incorporated in 2013 and is based in South San Francisco, California.
Top News
BTCUSD
+1.64%
Bitcoin losing $63k means crypto winter will not thaw any time soon as tariff shock rattles ETF flows
cryptoslate.com
10h ago
BTCUSD
+1.64%
Smarter Web Gains $30M Bitcoin Credit Line From Coinbase to Boost Buying - Blockonomi
blockonomi.com
10h ago
BTCUSD
+1.64%
Michael Saylor Confirmed As A Speaker For Bitcoin 2026
bitcoinmagazine.com
11h ago
Frequently Asked Questions
What are healthcare stocks and why are they important to investors?
Healthcare stocks include pharmaceutical companies, biotech firms, hospitals, and medical device manufacturers.
Are healthcare stocks less volatile?
Generally yes. Because healthcare is a necessity, demand remains relatively steady, making the sector less sensitive to economic cycles.
What drives growth in healthcare investments?
Aging populations, technological advancements, and increased healthcare spending contribute to long-term growth in the sector.
What are the risks of investing in healthcare?
Regulatory changes, drug approval delays, and legal challenges can affect the profitability and stock prices of healthcare companies.
